India-based CDMO Piramal sketches out $32M upgrade to Michigan drug ingredient facility

Another year, another expansion: After wrapping improvements on a Michigan API facility in 2019, Indian CDMO Piramal Pharma Solutions is at it again, laying plans for a second upgrade.

Piramal will invest some $32 million into its manufacturing plant in Riverview, Michigan, shoring up production and development for potent and non-potent active pharmaceutical ingredients (APIs) over the next two years.